Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.

Yaxin XieLiang ZhongDingyu DuanTaiwen Li

Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2019)

Casticin impaired invasion and migration of OSCC by inhibition of β-catenin and reversal of EMT and could be a potential anti-cancer bioactive agent.

Keyphrases

epithelial mesenchymal transition
signaling pathway
cell migration
cell proliferation
human health
risk assessment
tissue engineering